Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Cancer-associated genomic regions (CAGRs) and noncoding RNAs: bioinformatics and therapeutic implications.

Rossi S, Sevignani C, Nnadi SC, Siracusa LD, Calin GA.

Mamm Genome. 2008 Aug;19(7-8):526-40. doi: 10.1007/s00335-008-9119-8. Epub 2008 Jul 18. Review.

PMID:
18636290
2.

Fez1/Lzts1-deficient mice are more susceptible to N-butyl-N-(4-hydroxybutil) nitrosamine (BBN) carcinogenesis.

Baffa R, Fassan M, Sevignani C, Vecchione A, Ishii H, Giarnieri E, Iozzo RV, Gomella LG, Croce CM.

Carcinogenesis. 2008 Apr;29(4):846-8. doi: 10.1093/carcin/bgn006. Epub 2008 Jan 12.

PMID:
18192690
3.

Micro-RNA profiling in kidney and bladder cancers.

Gottardo F, Liu CG, Ferracin M, Calin GA, Fassan M, Bassi P, Sevignani C, Byrne D, Negrini M, Pagano F, Gomella LG, Croce CM, Baffa R.

Urol Oncol. 2007 Sep-Oct;25(5):387-92.

PMID:
17826655
4.

Ultraconserved regions encoding ncRNAs are altered in human leukemias and carcinomas.

Calin GA, Liu CG, Ferracin M, Hyslop T, Spizzo R, Sevignani C, Fabbri M, Cimmino A, Lee EJ, Wojcik SE, Shimizu M, Tili E, Rossi S, Taccioli C, Pichiorri F, Liu X, Zupo S, Herlea V, Gramantieri L, Lanza G, Alder H, Rassenti L, Volinia S, Schmittgen TD, Kipps TJ, Negrini M, Croce CM.

Cancer Cell. 2007 Sep;12(3):215-29.

5.

Tumor suppressor functions of ARLTS1 in lung cancers.

Yendamuri S, Trapasso F, Ferracin M, Cesari R, Sevignani C, Shimizu M, Rattan S, Kuroki T, Dumon KR, Bullrich F, Liu CG, Negrini M, Williams NN, Kaiser LR, Croce CM, Calin GA.

Cancer Res. 2007 Aug 15;67(16):7738-45.

6.

MicroRNA genes are frequently located near mouse cancer susceptibility loci.

Sevignani C, Calin GA, Nnadi SC, Shimizu M, Davuluri RV, Hyslop T, Demant P, Croce CM, Siracusa LD.

Proc Natl Acad Sci U S A. 2007 May 8;104(19):8017-22. Epub 2007 Apr 30.

7.

Tumor induced by Moloney sarcoma virus causes periosteal osteogenesis engaging osteopontin, fibronectin, stromelysin-1 and tenascin.

Wlodarski P, Sevignani C, Fernandes MJ, Calabretta B, Wlodarski KH.

Neoplasma. 2007;54(2):173-9.

PMID:
17319793
8.

Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster.

Dews M, Homayouni A, Yu D, Murphy D, Sevignani C, Wentzel E, Furth EE, Lee WM, Enders GH, Mendell JT, Thomas-Tikhonenko A.

Nat Genet. 2006 Sep;38(9):1060-5. Epub 2006 Jul 30.

9.

Mammalian microRNAs: a small world for fine-tuning gene expression.

Sevignani C, Calin GA, Siracusa LD, Croce CM.

Mamm Genome. 2006 Mar;17(3):189-202. Epub 2006 Mar 3. Review.

10.

Effect of rapamycin on mouse chronic lymphocytic leukemia and the development of nonhematopoietic malignancies in Emu-TCL1 transgenic mice.

Zanesi N, Aqeilan R, Drusco A, Kaou M, Sevignani C, Costinean S, Bortesi L, La Rocca G, Koldovsky P, Volinia S, Mancini R, Calin G, Scott CP, Pekarsky Y, Croce CM.

Cancer Res. 2006 Jan 15;66(2):915-20.

11.

A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia.

Calin GA, Ferracin M, Cimmino A, Di Leva G, Shimizu M, Wojcik SE, Iorio MV, Visone R, Sever NI, Fabbri M, Iuliano R, Palumbo T, Pichiorri F, Roldo C, Garzon R, Sevignani C, Rassenti L, Alder H, Volinia S, Liu CG, Kipps TJ, Negrini M, Croce CM.

N Engl J Med. 2005 Oct 27;353(17):1793-801. Erratum in: N Engl J Med. 2006 Aug 3;355(5):533.

12.

Lung cancer susceptibility in Fhit-deficient mice is increased by Vhl haploinsufficiency.

Zanesi N, Mancini R, Sevignani C, Vecchione A, Kaou M, Valtieri M, Calin GA, Pekarsky Y, Gnarra JR, Croce CM, Huebner K.

Cancer Res. 2005 Aug 1;65(15):6576-82.

13.

Adenoviral transduction of TESTIN gene into breast and uterine cancer cell lines promotes apoptosis and tumor reduction in vivo.

Sarti M, Sevignani C, Calin GA, Aqeilan R, Shimizu M, Pentimalli F, Picchio MC, Godwin A, Rosenberg A, Drusco A, Negrini M, Croce CM.

Clin Cancer Res. 2005 Jan 15;11(2 Pt 1):806-13.

14.

Inactivation of the FHIT gene favors bladder cancer development.

Vecchione A, Sevignani C, Giarnieri E, Zanesi N, Ishii H, Cesari R, Fong LY, Gomella LG, Croce CM, Baffa R.

Clin Cancer Res. 2004 Nov 15;10(22):7607-12.

15.

MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias.

Calin GA, Liu CG, Sevignani C, Ferracin M, Felli N, Dumitru CD, Shimizu M, Cimmino A, Zupo S, Dono M, Dell'Aquila ML, Alder H, Rassenti L, Kipps TJ, Bullrich F, Negrini M, Croce CM.

Proc Natl Acad Sci U S A. 2004 Aug 10;101(32):11755-60. Epub 2004 Jul 29.

16.

An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues.

Liu CG, Calin GA, Meloon B, Gamliel N, Sevignani C, Ferracin M, Dumitru CD, Shimizu M, Zupo S, Dono M, Alder H, Bullrich F, Negrini M, Croce CM.

Proc Natl Acad Sci U S A. 2004 Jun 29;101(26):9740-4. Epub 2004 Jun 21.

17.

Myc-transformed epithelial cells down-regulate clusterin, which inhibits their growth in vitro and carcinogenesis in vivo.

Thomas-Tikhonenko A, Viard-Leveugle I, Dews M, Wehrli P, Sevignani C, Yu D, Ricci S, el-Deiry W, Aronow B, Kaya G, Saurat JH, French LE.

Cancer Res. 2004 May 1;64(9):3126-36.

18.

Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers.

Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S, Shimizu M, Rattan S, Bullrich F, Negrini M, Croce CM.

Proc Natl Acad Sci U S A. 2004 Mar 2;101(9):2999-3004. Epub 2004 Feb 18.

19.

Restoration of fragile histidine triad (FHIT) expression induces apoptosis and suppresses tumorigenicity in breast cancer cell lines.

Sevignani C, Calin GA, Cesari R, Sarti M, Ishii H, Yendamuri S, Vecchione A, Trapasso F, Croce CM.

Cancer Res. 2003 Mar 15;63(6):1183-7.

20.

The fragile histidine triad/common chromosome fragile site 3B locus and repair-deficient cancers.

Turner BC, Ottey M, Zimonjic DB, Potoczek M, Hauck WW, Pequignot E, Keck-Waggoner CL, Sevignani C, Aldaz CM, McCue PA, Palazzo J, Huebner K, Popescu NC.

Cancer Res. 2002 Jul 15;62(14):4054-60.

21.

Cutting edge: systemic inhibition of angiogenesis underlies resistance to tumors during acute toxoplasmosis.

Hunter CA, Yu D, Gee M, Ngo CV, Sevignani C, Goldschmidt M, Golovkina TV, Evans S, Lee WF, Thomas-Tikhonenko A.

J Immunol. 2001 May 15;166(10):5878-81.

22.

Activation of the myc oncoprotein leads to increased turnover of thrombospondin-1 mRNA.

Janz A, Sevignani C, Kenyon K, Ngo CV, Thomas-Tikhonenko A.

Nucleic Acids Res. 2000 Jun 1;28(11):2268-75.

23.

Direct transactivation of the anti-apoptotic gene apolipoprotein J (clusterin) by B-MYB.

Cervellera M, Raschella G, Santilli G, Tanno B, Ventura A, Mancini C, Sevignani C, Calabretta B, Sala A.

J Biol Chem. 2000 Jul 14;275(28):21055-60.

24.

Spontaneous and mutagen-induced transformation of primary cultures of Msh2-/- p53-/- colonocytes.

Sevignani C, Cranston A, Iozzo RV, Fishel R, Calabretta B.

Cancer Res. 1999 Dec 1;59(23):5882-6.

25.

Tumorigenic conversion of p53-deficient colon epithelial cells by an activated Ki-ras gene.

Sevignani C, Wlodarski P, Kirillova J, Mercer WE, Danielson KG, Iozzo RV, Calabretta B.

J Clin Invest. 1998 Apr 15;101(8):1572-80.

26.

Role of p53 in hematopoietic recovery after cytotoxic treatment.

Wlodarski P, Wasik M, Ratajczak MZ, Sevignani C, Hoser G, Kawiak J, Gewirtz AM, Calabretta B, Skorski T.

Blood. 1998 Apr 15;91(8):2998-3006.

PMID:
9531612
27.

Effects of peptide T derivatives on the proliferation of cultured human keratinocytes.

Marastoni M, Scaranari V, Fantini F, Sevignani C, Tomatis R.

Arzneimittelforschung. 1995 Aug;45(8):891-3.

PMID:
7575755
28.

Expression and function of nerve growth factor and nerve growth factor receptor on cultured keratinocytes.

Pincelli C, Sevignani C, Manfredini R, Grande A, Fantini F, Bracci-Laudiero L, Aloe L, Ferrari S, Cossarizza A, Giannetti A.

J Invest Dermatol. 1994 Jul;103(1):13-8.

29.

Autoradiographic detection of substance P receptors in normal and psoriatic skin.

Pincelli C, Fantini F, Giardino L, Zanni M, Calz√° L, Sevignani C, Giannetti A.

J Invest Dermatol. 1993 Sep;101(3):301-4.

30.
31.

Cutaneous innervation in chronic renal failure patients. An immunohistochemical study.

Fantini F, Baraldi A, Sevignani C, Spattini A, Pincelli C, Giannetti A.

Acta Derm Venereol. 1992;72(2):102-5.

PMID:
1350391
32.

Langerhans cells can express neuron-specific enolase immunoreactivity.

Fantini F, Pincelli C, Sevignani C, Baraldi A, Giannetti A.

Arch Dermatol Res. 1991;283(1):10-2. No abstract available.

PMID:
2059056

Supplemental Content

Loading ...
Support Center